Reported Earlier, Boundless Bio Prices Initial Public Offering Of 6.25M Common Shares At $16/Share
Portfolio Pulse from Benzinga Newsdesk
Boundless Bio has priced its IPO at $16 per share, offering 6.25M shares with expected gross proceeds of $100M. The stock, under the ticker 'BOLD', is set to begin trading on the Nasdaq Global Select Market on March 28, 2024, with the offering closing on April 2, 2024.
March 28, 2024 | 6:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boundless Bio's IPO is priced at $16 per share, aiming to raise $100M by offering 6.25M shares. Trading on Nasdaq starts March 28, 2024.
The successful pricing of Boundless Bio's IPO and its upcoming listing on the Nasdaq are significant positive developments for the company. The anticipation of the IPO and the details provided about the offering size and expected proceeds are likely to generate investor interest and could lead to a positive short-term impact on the stock price once trading begins.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100